Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Giant Cell Arteritis”

187 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 187 results

Large-scale testing (Phase 3)Study completedNCT03263715
What this trial is testing

Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

Who this might be right for
Polymyalgia Rheumatica
Medical University of Vienna 39
Not applicableUnknownNCT05045001
What this trial is testing

Pharmacogenetic Studies on Anti-IL-6 Receptor Monoclonal Antibodies on the Treatment of Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisIdiopathic Juvenile ArthritisGiant Cell Arteritis+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 140
Not applicableStudy completedNCT06011512
What this trial is testing

Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.

Who this might be right for
Giant Cell ArteritisPolymyalgia RheumaticaLarge Vessel Vasculitis
Salome Kristensen 198
Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7
Post-approval studies (Phase 4)UnknownNCT03244709
What this trial is testing

Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.

Who this might be right for
Giant Cell Arteritis
Hospital of Prato 15
Not applicableLooking for participantsNCT06460142
What this trial is testing

Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic

Who this might be right for
Giant Cell ArteritisPolymyalgia Rheumatica
University of Bonn 100
Not applicableStudy completedNCT02190942
What this trial is testing

VCRC Patient Contact Registry Patient-Reported Data Validation Study

Who this might be right for
Behcet's DiseaseChurg-Strauss SyndromeGiant Cell Arteritis+4 more
University of South Florida 198
Testing effectiveness (Phase 2)Study completedNCT04027101
What this trial is testing

BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica

Who this might be right for
Polymyalgia Rheumatic (PMR)
University Hospital, Brest 34
Not applicableStudy completedNCT02476292
What this trial is testing

Impact of Vasculitis on Employment and Income

Who this might be right for
VasculitisSystemic VasculitisBehcet's Disease+10 more
University of South Florida 426
Post-approval studies (Phase 4)Looking for participantsNCT07286214
What this trial is testing

Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

Who this might be right for
Polymyalgia Rheumatica
Sanofi 300
Not applicableStudy completedNCT00974883
What this trial is testing

Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)

Who this might be right for
Giant Cell Arteritis
University of Oxford 880
Very early researchUnknownNCT00361192
What this trial is testing

Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis

Who this might be right for
Temporal ArteritisDuplex of Temporal ArteryBiopsy of Temporal Artery
Shaare Zedek Medical Center
Early research (Phase 1)Ended earlyNCT06281236
What this trial is testing

A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)

Who this might be right for
Polymyalgia Rheumatica
Sparrow Pharmaceuticals 1
Not applicableNot Yet RecruitingNCT07354906
What this trial is testing

Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

Who this might be right for
Giant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil 80
Large-scale testing (Phase 3)Looking for participantsNCT04474847
What this trial is testing

Abatacept for the Treatment of Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
University of Pennsylvania 78
Not applicableLooking for participantsNCT06894602
What this trial is testing

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
University Hospital, Brest 100
Not applicableStudy completedNCT01795456
What this trial is testing

Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis

Who this might be right for
Takayasu's ArteritisGiant Cell ArteritisArteritis+2 more
The Cleveland Clinic 7
Not applicableNot Yet RecruitingNCT06558357
What this trial is testing

Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica

Who this might be right for
Inflammatory Rheumatism18-FDGPositron-emission Tomography
University Hospital, Brest 210
Large-scale testing (Phase 3)Study completedNCT05380453
What this trial is testing

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission

Who this might be right for
Giant Cell Arteritis
Novartis Pharmaceuticals 151
Not applicableUnknownNCT04397237
What this trial is testing

Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe

Who this might be right for
COVID-19Systemic Lupus ErythematosusSjogren's Syndrome+3 more
Pitié-Salpêtrière Hospital 3,100
Load More Results